14 results
8-K
EX-10.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling
8-K
EX-1.1
NEXI
Neximmune Inc
17 Jun 22
Entry into a Material Definitive Agreement
4:51pm
for examination and packaging by the Designated Agent in The City of New York not later than noon (New York time) on the Business Day prior to the Settlement … , packaging, processing, use, distribution, marketing, advertising, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any
10-K
2020 FY
NEXI
Neximmune Inc
31 Mar 21
Annual report
4:02pm
in other jurisdictions, there will be additional regulation relating to the packaging, distribution, marking, marketing and claims of our potential … extensively regulate, among other things, the research, development, testing, manufacturing, quality control, approval, labeling, packaging, storage
424B4
laz9p
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
EX-1.1
8bb6t9z77vdbzk6m1q2n
8 Feb 21
IPO registration (amended)
7:29am
S-1/A
q36hwpjs04i 32
8 Feb 21
IPO registration (amended)
7:29am
S-1
b94n zbj0b1j
19 Jan 21
IPO registration
4:38pm
S-1
EX-10.11
8ngz il7z
19 Jan 21
IPO registration
4:38pm
DRS/A
e22 y4ebx
15 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.11
65wqkco
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
jz1dtu
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next